Now showing items 1-2 of 2

  • Different dietary approaches for the treatment of obesity and the phenotypic responses to these diets. 

    Hession, Michelle (The Robert Gordon University Centre for Obesity Research and Epidemiology, Faculty of Health and Social Care, 2009-04)
    HESSION, M., ROLLAND, C., KULKARNI, U., WISE, A., BROOM, J., 2008. Systemic review of randomised controlled trials of low carbohydrate vs low fat/low calorie diets in the management of obesity and its comorbidities. Obesity Reviews.
     
    HESSION, M., ROLLAND, C., AVENELL, A., WISE, A. and BROOM, I., 2005. Systematic review of randomised control trials for the prevention, treatment and management of obesity and its comorbidities. Obesity Reviews, 6 (S155)
     
    WISE, A., ROLLAND, C., COX, J., HEWLETT, B., HESSION, M. and BROOM, I., 2005. The role of the LighterLife weight loss programme in lowering the cost of obesity. Obesity Reviews 6 (S156)
     
    HESSION, M., ROLLAND, C., TUYA, C., WISE, A., MURRAY, S., PIRIE, I., JARRETT, K. and BROOM, J., 2006. Weight, physical activity, and general health changes after 3 and 6 months of dietary interventions. Obesity Reviews, 7 (S307)
     
    HESSION, M., ROLLAND, C., WISE, A., TUYA, C., MURRAY, S., BROOM, J., 2006. Physical activity, general health and depression analysis in relation to weight change after 3 months of a healthy eating dietary intervention. Obesity Reviews, 7 (S307)
     
    ROLLAND, C., HESSION, M., TYUA, C., MURRAY, S., JARRETT, K., WISE, A. and BROOM, J., 2006. Reported weight loss for a 1 yr randomised controlled trial examining 3 dietary interventions for obesity management - initial findings. In: Proceedings of the Nutrition Society, 65 (117A)
     
    ROLLAND, C., HESSION, M., TUYA, C., MURRAY, S., JARRETT, K., WISE, A. and BROOM, J., 2006. The effects of a randomised control trial of low fat and high protein diets on cardiovascular risk of morbidly obese patients. Obesity Reviews, 7 (S307)
     
    ROLLAND, C., HESSION, M., TUYA, C., MURRAY, S., WISE, A. and BROOM, J., 2006. Phenotypic presentation of an obese population and their response to a healthy eating energy deficient diet. Obesity Reviews, 7 (S202)
     
    ROLLAND, C., HESSION, M., JOHN, O., MURRAY, S., WISE, A. and BROOM, J., 2007. Occurence and diagnosis of Type II diabetes in an obese population. International Journal of Obesity,, 31 (S128)
     
    ROLLAND, C., STEWART, A., HESSION, M., JOHN, O., MURRAY, S. and BROOM, J., 2007. Analysis of insulin sensitivity in response to weight loss in obese patients. Diabetes and Vascular Disease Research, 4 pp. 255
     
    HESSION, M., ROLLAND, C., JOHN, O., MURRAY, S., WISE, A. and BROOM, J., 2008. Comparison of kidney and liver changes after 3 months of a low carbohydrate vs. a a very low calorie diet. International Journal of Obesity, 32 (S1)
     
    ROLLAND, C., HESSION, M., JOHN, O., MURRAY, S., WISE, A. and BROOM, J., 2008. Baseline differences between achievers and non achievers of weight loss in a 3 month period with a healthy eating weight loss regimen. International Journal of Obesity, 32 (S106)
     
    Currents treatments for obesity have been unsuccessful. It is essential that a patient-centred approach for obesity management is developed and for this to be successful other diet and lifestyle approaches need to be ...
  • Weight loss for women with and without polycystic ovary syndrome following a very low-calorie diet in a community-based setting with trained facilitators for 12 weeks. 

    Nikokavoura, Efsevia Anastasia; Johnston, Kelly L.; Broom, John; Wrieden, Wendy L.; Rolland, Catherine (Dove Medical Press http://dx.doi.org/10.2147/DMSO.S85134, 2015-10)
    NIKOKAVOURA, E. A., JOHNSTON, E. L., BROOM, J., WRIEDEN, W. L. and ROLLAND, C., 2015. Weight loss for women with and without polycystic ovary syndrome following a very low-calorie diet in a community-based setting with trained facilitators for 12 weeks. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 2015:8, pp. 495-503.
    Background: Polycystic ovary syndrome (PCOS) affects between 2% and 26% of reproductive-age women in the UK, and accounts for up to 75% of anovulatory infertility. The major symptoms include ovarian disruption, hyperandrogenism, ...